Chris Smith is an Investment Manager at Brandon Capital Partners with over 15 years’ scientific and commercial experience in the pharmaceutical industry. He was formerly a Business Development Manager with CSL Ltd and has experience with both in and out-licensing of therapeutic drugs and R&D enabling platforms.

Dr Smith received his PhD at the Walter and Eliza Hall Institute, Australia and his MBA (specialising in innovation and entrepreneurship) from the University of Cambridge, U.K.